Regulatory Considerations DMEG reviews recent MHRA regulatory updates
Date: April 22, 2026
The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent publications from the UK Medicines and Healthcare products Regulatory Agency (MHRA) including the release of new guidelines, updates to the Inspection Dossier templates and annotations to ICH E6 (R3) and ICH E8 (R1). These guidelines go into effect on April 28, 2026.
To assist data managers in complying with the new guidelines, the DMEG is releasing a summary of the highlights which impact data managers including:
- o AI/ML documentation for Data Management
- o Clinical trial record archiving and retention
- o Data protection and subject rights
View the paper here
The Regulatory Considerations DMEG will continue to review MHRA guidance as they are published, and an upcoming review will be on the Guidance on quality and risk proportionality (published 27 March 2026). In the interim, you can access that document at the MHRA Clinical Trial Hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-guidance-on-quality-and-risk-proportionality
Explore More News

Welcome LINK Medical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome LINK Medical as . . .
Read More

Welcome Zilla Clinicals as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Zilla Clinicals . . .
Read More

Challenge ChatGPT: CDMs vs AI
Following a recent Hot Topic discussion that explained how machine learning models are . . .
Read More

Welcome Boehringer Ingelheim as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Boehringer . . .
Read More

Welcome Datacapt as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Datacapt as a . . .
Read More

Welcome Climedo as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Climedo as a . . .
Read More

Clinical Trials for Medicines – New Notification Scheme
The MHRA have recently launched a new notification scheme, the first step in their . . .
Read More

EMA Management Board: Highlights of October 2023 meeting
The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .
Read More

Welcome Mednet as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .
Read More

Welcome Allucent as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .
Read More

Welcome KCR as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .
Read More

Welcome Debiopharm as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .
Read More